ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1729

Adenosine A2A Receptor (A2AR) Promotes Collagen Type 3 Expression Via β-Catenin Activation

Miguel Perez-Aso1 and Bruce N. Cronstein2, 1545 1st Ave., New York University, New York City, NY, 2NYU School of Medicine, Division of Rheumatology, New York, NY

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Adenosine receptors, Cell Signaling, Collagen, fibrosis and skin fibrosis

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Pathogenesis, Animal Models and Genetics

Session Type: Abstract Submissions (ACR)

Background/Purpose A2AR stimulation promotes collagen 1 and 3 (Col1 and Col3) synthesis, principal mediators of fibrosis and scarring. We have recently demonstrated that the A2AR is a fine-tune modulator of collagen balance that signals via PKA/EPAC2/AKT but is independent of Smad2/3 signaling. Wnt signaling is an important player in the progression of fibrosis, and other recent studies have suggested that cAMP and Wnt pathways converge. Since A2AR is Gs-linked and increases cAMP, we determined whether A2AR and Wnt signaling interact. 

Methods : Primary human dermal fibroblasts (<5 passages) were stimulated by the A2AR-selective agent CGS21680 (1μM) and β-catenin, dephosphorylated β-catenin and β-catenin phospho-Ser552 levels were determined in cytosolic and nuclear fractions by Western Blot. Nuclear translocation of β-catenin was determined by confocal microscopy.  β-catenin was knocked down by transfection with specific-siRNA or scrambled-siRNA and protein levels determined by Western Blot. 

Results Stimulation of A2AR rapidly (15 min) increases cellular β-catenin levels to 196±13% of control (N=3, P<0.01). Similarly CGS21680 stimulates de-phosphorylation of β-catenin (188±27% of control; N=5, P<0.05) and promotes β-catenin phosphorylation at Ser 552 (239±15% of control; N=5, P<0.001), the site of β-catenin activation by AKT.  Furthermore, CGS21680 stimulates translocation of β-catenin to the nucleus, as confirmed by confocal microscopy and Western Blot. We next knocked down β-catenin (54±5% decrease in β-catenin siRNA vs scramble siRNA; N=10, P<0.001) and determined the effect of A2AR stimulation on collagen production. A2AR-stimulated increases in Col1 scramble-siRNA transfected cells (63±22% increase, N=7) which were unaffected by β-catenin knockdown (53±17% increase, N=7). In contrast, β-catenin knockdown abrogates A2AR-stimulated increments in Col3 synthesis by 73% (scramble-siRNA 66±14% increase of Col3 vs β-catenin-siRNA 18±16% increase of Col3; P<0.05, N=8). 

Conclusion Our results strongly indicate that A2AR stimulation activates both canonical and non-canonical Wnt pathways for increased Col3 synthesis, leading to dermal fibrosis and excessive scarring.


Disclosure:

M. Perez-Aso,
None;

B. N. Cronstein,

Canfite Pharma,

1,

AstraZeneca,

2,

Cellgene,

2,

Gilead,

2,

NIH,

2,

NYU School of Medicine,

3,

Bristol-Myers Squibb,

5,

Pfizer Inc,

5,

Eli Lilly and Company,

5,

Rheumatology Reseach Foundation,

6,

ACR,

6,

Arthritis Foundation,

6.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/adenosine-a2a-receptor-a2ar-promotes-collagen-type-3-expression-via-%ce%b2-catenin-activation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology